CD44 and head and neck squamous cell carcinoma: In fact, β-catenin has recently been shown to upregulate stemness markers such as CD44 and EGFR in HNSCC [48–50], reassuring our observations and the therapeutic potential of targeting KRT17-mediated signaling pathway.